Research interests
Areas of research interest include fundamental research on diseases to identify potential drug targets, computer modelling for hit discovery, preclinical models for drug activity and toxicity, and work with patients.
- Molecular basis of disease (Poulsen) and human neurodegeneration (Dragunow, Connor, Smith, Rustenhoven)
- Neural reprogramming and repair (Connor, McCaughey-Chapman)
- Protein structure and the molecular basis of drug action (Flanagan, Grimsey)
- New therapies for brain diseases (Connor, Dragunow, Young, Park, McCaughey-Chapman, Rustenhoven)
- Receptor signalling and disease (Grimsey)
- Preclinical pharmacology for anticancer drugs (Flanagan, Jamieson, Tingle, Park)
- Drug metabolism and toxicology (Tingle)
- Clinical pharmacology, including cancer clinical trials, paediatric pharmacology and drugs used during surgery (Hannam, Burns, Tingle)
- Disease progression and drug action (Hannam)
- Neurodegenerative blood biomarkers (Cawston)